The 14th Conference on Retroviruses and Opportunistic Infections (CROI 2007) took place in Los Angeles, California, on February 25-28, 2007. This scientifically focused meeting covered a variety of HIV-related topics, including molecular epidemiology, immunology, virology, pathogenesis and the treatment and prevention of HIV infection. This article summarizes important presentations related to antiretroviral therapy that were made at the meeting. Highlights included efavirenz-associated lipoatrophy, the antiHIV activity of entecavir and phase III results for two novel first-in-class antiretroviral agents: maraviroc and raltegravir.
|Original language||English (US)|
|Number of pages||8|
|Journal||Drugs of the Future|
|State||Published - May 1 2007|
ASJC Scopus subject areas
- Pharmacology (medical)